You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 6, June 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  From JAMA
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Deep Brain Stimulation
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Enough Is Enough

Moving on to Deep Brain Stimulation in Patients With Fluctuating Parkinson Disease

Michael S. Okun, MD; Kelly D. Foote, MD

Arch Neurol. 2009;66(6):778-780.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

JAMA

Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial

Frances M. Weaver, PhD; Kenneth Follett, MD, PhD; Matthew Stern, MD; Kwan Hur, PhD; Crystal Harris, PharmD; William J. Marks Jr, MD; Johannes Rothlind, PhD; Oren Sagher, MD; Domenic Reda, PhD; Claudia S. Moy, PhD; Rajesh Pahwa, MD; Kim Burchiel, MD; Penelope Hogarth, MD; Eugene C. Lai, MD, PhD; John E. Duda, MD; Kathryn Holloway, MD; Ali Samii, MD; Stacy Horn, DO; Jeff Bronstein, MD, PhD; Gatana Stoner, RN, CCRC; Jill Heemskerk, PhD; Grant D. Huang, PhD; for the CSP 468 Study Group

Context:  Deep brain stimulation is an accepted treatment for advanced Parkinson disease (PD), although there are few randomized trials comparing treatments, and most studies exclude older patients.

Objective:  To compare 6-month outcomes for patients with PD who received deep brain . . . [Full Text of this Article]

INTERDISCIPLINARY AND MULTIDISCIPLINARY SCREENING


IMPORTANCE AND DIFFICULTY OF INCLUDING A MEDICAL THERAPY GROUP IN DBS STUDIES

OLDER AGE AND DBS

MOTOR IMPROVEMENTS

QUALITY OF LIFE IMPROVES WITH DBS

COGNITIVE WORSENING WITH DBS

ADVERSE EVENT REPORTING NEEDS TO IMPROVE IN DBS STUDIES

CONCLUSIONS

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial
Frances M. Weaver, Kenneth Follett, Matthew Stern, Kwan Hur, Crystal Harris, William J. Marks, Jr, Johannes Rothlind, Oren Sagher, Domenic Reda, Claudia S. Moy, Rajesh Pahwa, Kim Burchiel, Penelope Hogarth, Eugene C. Lai, John E. Duda, Kathryn Holloway, Ali Samii, Stacy Horn, Jeff Bronstein, Gatana Stoner, Jill Heemskerk, Grant D. Huang, and for the CSP 468 Study Group
JAMA. 2009;301(1):63-73.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.